Skin cancer: Fundamentals of diagnosis and treatment Surgical training meeting, Worcester,6 th September 2017 Simon De Vos, FRCS MRCGP Specialty Dr,

Slides:



Advertisements
Similar presentations
Detection and Treatment of Non-Melanoma Skin Cancers
Advertisements

Skin Pre-Cancer and Cancer
Skin Pathology, Case 3 40 year-old female with no significant past medical history presents with a 1 cm pigmented lesion on the back. The borders are irregular.
Basal Cell Nevus Syndrome Daniel Berg M.D., FRCPC Director, Dermatologic Surgery University of Washington.
Skin Cancer A few questions A few photos A few suggestions Dr Peter Allen.
SQUAMOUS CELL CARCINOMA
NonMelanoma Skin Cancer Dr David Burdon-Jones Consultant Dermatologist Dorset County Hospital Foundation Trust Interactive.
Nonmelanoma Skin Tumor
Skin Lesion James Warneke, MD University of Arizona.
Eyelid Cancer and Reconstruction
Rob Sheehan-Dare Leeds Centre for Dermatology
National Specialist Dermatopathology EQA Scheme Circulation A.
MALIGNANT EYELID TUMOURS
Skin tumors & nevi By: Dr. Kazhan Ali Tofiq Kadir Dr. Kazhan Ali Tofiq Kadir April 2014 April 2014.
Sun safety Lesley Pallett Workforce Health & Wellbeing Specialist Advisor and Ian Murray Dermatology Nurse.
Psoriasis & Skin Cancer
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
Psoriasis and Skin Cancer Edward Pritchard. Long Cases You could get these! Last year’s finals! - Patient with recurrent SCC, with no symptoms. History.
Skin(epidermal) tumors
Your Skin J. C. DiGiacomo, M.D., FACS Department of Surgery CentraState Medical Center.
SKIN CANCER Dr. D. Czarnecki MD MBBS. Skin Cancer Skin cancer is a major health problem in AustraliaSkin cancer is a major health problem in Australia.
SIAscope Training Course Micro-architecture of skin lesions.
SKIN CANCER KARINA PARR, MD RONALD GRIMWOOD, MD KARA KENNEY.
Cutaneous Malignancies
Burns Burns are categorized by severity as first, second, or third degree. First degree burns are similar to a painful sunburn, causing redness and swelling.
S KIN C ANCER Kathy Sheriff, RN, BSN. S KIN C ANCER One in five Americans Crucial risk factor—over exposure to UV radiation in sunlight Other cases, frequent.
Skin Cancers Pages
C&H Skin Cancer Referral Pathway 2013 Dr Sara Ritchie CCG GP Dermatology Lead.
DR. OLGA WATKINS November Outline Of Presentation Common Skin Lesions, Benign And Malignant Assessment Of Pigmented Lesion Points to take home.
BCCs & GPs Dr Victoria Brown Consultant Dermatologist West Hertfordshire Hospitals NHS Trust.
Basal Cell Carcinoma. Basal Cell Carcinoma Basal Cell Carcinoma.
Skin Cancer Skin cancer is the most common type of cancer
Skin tumors. Melanocytic naevi Melanocytic naevi are normal, benign proliferations of melanocytes. Although the risk of a naevus evolving into a melanoma.
Cancer Invasive cellular neoplasm that has the capability of spreading throughout the body or body parts; uncontrolled cell growth.
Common MMalignant Skin Tumours, M elanoma, Biopsy M ethods, Surgical
CLASSIFICATION OF CUTANEOUS MALIGNANCIES. 1- PREMALİGNANCİES (in situ) Actinic keratosis Actinic keratosis Bowen’s disease Bowen’s disease Lentigo maligna.
Krisinda C. Dim-Jamora, MD, FPDS Section of Dermatology, The Medical City Department of Dermatology, Makati Medical Center Skin and Cancer Foundation,
Photodynamic Therapy for Pre-cancerous lesions of the skin Alan Milligan Clinical Nurse Specialist for Non-Melanoma Skin Cancers.
MALIGNANT MELANOMA. Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention.
A&P WED-THU, 12/10-12/11 1.Complete overview of Integumentary System 2. Skin Cancers? 3.Study for Unit Quiz on WED 4.Integumentary Syst. Quiz on THU.
MELANOMA Stephen G. Mallette, D.O. Athens, Alabama.
The Integumentary System
“Malignant skin tumors”
Skin and Soft-Tissue Lesions
MALIGNANT MELANOMA.
INFECTIONS Allergies, Fungal, Bacterial, Viral, Infection, Inflammation, and Genetic.
Dolianitis C, Kelly J Victorian Melanoma Service,
Skin Cancer Diagnoses and Treatments.
Seborrheic keratosis eyelid
Skin Cancer A Colorado Concern.
Dermoscopy Workshop An Introduction to Dermoscopy
Skin Cancer Can be benign or malignant
Skin tumors.
Psoriasis and Skin Cancer
Sun & Skin Dr Robin Pullen.
Mary Collier, FCSE, MS Texas AgriLIFE Extension Service, Terry County
SKIN CANCER NOTES.
Malignant Melanoma.
‘Improving Outcomes for people with skin tumours, including Melanoma’
Advanced Biology Burns Skin Cancer.
Do now activity #2 What is the physiology of sebaceous glands?
Pathophysiology Unregulated cell growth and uncontrolled cell division result in the development of neoplasm.  Basal cell keratinization causes basal cells,
Lecture #2 Common Skin Lesions and Skin Malignancies
SKIN NEOPLASM (OVERVIEW)
Principles and Practice of Radiation Therapy
Presentation transcript:

Skin cancer: Fundamentals of diagnosis and treatment Surgical training meeting, Worcester,6 th September 2017 Simon De Vos, FRCS MRCGP Specialty Dr, skin cancer, Worcester and Oxford, GPwSI skin lesions and skin surgery Member of West Midlands skin cancer expert advisory group GP partner, Corbett Medical Practice, Droitwich

Quiz Green card: Benign Amber card: Routine surgery, Cryotherapy, GP treatment advice Red card: 2ww – urgent surgery

Overview of diagnosis “Does it produce keratin?” Squamous cell line Pathological process: think of cell of origin : Squamous cell line from keratinocytes: produces keratin Basal cell line from basal stem cells: usually does not produce keratin, soft, ulcerates Melanocytic cell line from melanocytes: produces melanin not keratin “Does it produce keratin?”

SCC Keratin producing Hard keratin – like nails – adherent Quicker growing – 6 weeks to 12 months classically SCC has dermal induration or ‘meat’ arising from dermis – not flat No sheen of BCC Can be sore (BCCs and melanomas tend not to be) Treat Keratoacanthomas (quick growth, stabilising) as SCC

Actinic (Solar) Keratosis Keratin producing No dermal induration (no ‘meat’) Mild, moderate and severe dysplaisa Severe dysplaisia / in situ SCC = Bowen’s or Bowenoid Actinic Keratosis 1:500 to 1:1000 chance of invasive transformation

BCC Not keratin producing May have scab (fibrin) – picks off easily, ulcer under Slow growing – years Pull tight – look for sheen / reflection of light, pearly grey Not generally painful Bleeds / ulcerates early as soft ‘base’ cells Can arise in flat superficial BCC

Melanoma From melanocytes – not keratotic (unlike Seborrhoeic Keratosess) Change in 3-12m significant Think ‘ink in skin’ before nodular / thickened Beware ‘ugly duckling’ mole ‘Blue naevus’ that is new or not seen on back should raise suspicion ABCD of moles – does not work for seb Ks

ABCD of melanocytic lesions change within 3,6,12m : Asymmetry: Ectopic focus of pigment is significant Pizza analogy for symmetry Border Change to irregular Colour More than one colour, lighter or darker Diameter increasing

Cancer mimics Irritated Seborrhoeic Keratoses (?SCC) – Betnovate for 2 weeks Pigmented seb Ks (?MM) – look for others / stuck-on (side light) Sebaceous Hyperplaisia (?BCC) – multiple on face, no loss of sweat pore dimpling, symmetrical florets Dermatofibroma (? SCC)– no growth, marble in skin Lichenoid keratosis: (?LM) – solar lentigo  inflammation  slate grey ‘iron filings’ after (tricky)

Urgent excision / biopsy Melanoma Melanoma in situ Lentigo Maligna SCC and hypertrophic Actinic Keratoses Keratoacanthoma pigmented BCC if unsure Other nodular lesions of uncertain pathogenesis (think Merkel cell etc)

Routine excision / biopsy BCC of all types (NICE – critical sites excluded) Actiinic Keratoses and Bowen’s resistant to 5-FU (‘Efudix’)

BCC treatment options Nodular: 4mm margin excision – beware critical sites Superficial (face): 4mm margin excision – beware critical sites Superficial (body): 1. Shave Currettage and cautery x2 or x3 2 . Imiquimod cream 3. Photodynamic Therapy (PDT) Infiltrative: T-zone of face: Mohs micrographic surgery http://www.bad.org.uk/shared/get-file.ashx?id=107&itemtype=document Other: Radiotherapy MDT referral for incomplete excisions Follow up: Not always required

SCC treatment options <2cm diameter: 4mm margin excision Transplant patients: consider Shave C&Cx3 to preserve skin MDT referral for all cases unless Keratoacanthoma confirmed Follow up (low risk): 2-3months (x1) Follow up (high risk): 2 years (x4) High risk sites: ears, lips, scars High risk features: >2cm, poorly diff, perineural invasion, depth>4mm, desmoplastic, recurrent

Actinic Keratosis treatment options Nothing 5% 5-Fluorouracil (Efudix cream) – twice daily until flare Shave C&Cx2 or x3 Cryotherapy Less commonly ‘Picato’ topical treatment 2-3 doses

Melanoma treatment options 2mm excision margin initially Re-excision dependant on depth and MDT review (all cases) Full body photos Insitu (includes LM): 5mm margin re-excisison <1mm: 10mm margin re-excision >1mm or MDT: 20mm margin re-excision consider sentinal lymph node biopsy Follow up Insitu / LM: 3months (x1) Stage 1a: 1 year (x2-4) Stage 1b+: 5 years

Histopath forms Details Excision or Incisional biopsy… speed of growth Nodular / flat Pigmented / pink Keratotic / not keratotic Excision or Incisional biopsy…

Excision vs Incisional biopsy

Quiz repeat Green card: Benign – back to GP Amber card: Routine management Red card: 2ww – urgent management

Any Questions?